Disclosures for " Treatment-related Characteristics Among Younger Women with Generalized Myasthenia Gravis"
-
Jacqueline Pesa has received personal compensation for serving as an employee of Johnson and Johnson.
-
Dr. Jackson has received personal compensation for serving as an employee of Janssen Pharmaceuticals.
-
Alexander Keenan has received personal compensation for serving as an employee of Janssen Pharmaceuticals. Alexander Keenan has received stock or an ownership interest from Johnson and Johnson.
-
Dr. Campbell has received personal compensation for serving as an employee of Johnson and Johnson.
-
Mr. Gibson has nothing to disclose.
-
Mr. Conyers has nothing to disclose.
-
Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Goyal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Goyal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Goyal has received research support from Argenx.